- Senior Scientist, Emerging Viral Pathogens Section
Dr. Jahrling received his Ph.D. in medical microbiology from Cornell Medical College. Upon graduation, he served as an Army officer at the U.S. Army Medical Research Institute of Infectious Diseases, where he specialized in viral hemorrhagic fevers requiring biosafety level (BSL)-4 containment. After fulfillment of his military obligation, Dr. Jahrling converted to civilian status and was eventually appointed scientific advisor for the institute. In 2005, Dr. Jahrling accepted appointments as chief scientist of the NIAID Integrated Research Facility in Frederick, Maryland, and chief of the Emerging Viral Pathogens Section.
- (2020). Filoviruses Infect Rhesus Macaque Synoviocytes in Vivo and Primary Human Synoviocytes in Vitro. AMERICAN JOURNAL OF PATHOLOGY. 190(9), 1867-1880.
- (2020). Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections. Expert Review of Vaccines. 19(1), 85-103.